Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Increased insulin dose requirement of long-acting insulin analogues in obese patients with type 2 diabetes.

× No keyword cloud information.

6 in total

1. Omitting breakfast and lunch after injection of different long-acting insulin preparations at bedtime: a prospective study in patients with type 2 diabetes.

Authors: P Wiesli; P Krayenbühl; H Uthoff; B Seifert; C Schmid
Journal: Diabetologia Date: 2009-06-30 Impact factor: 10.122

2. Does diabetes therapy influence the risk of cancer?

Authors: U Smith; E A M Gale
Journal: Diabetologia Date: 2009-09 Impact factor: 10.122

3. A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes.

Authors: Kjeld Hermansen; Melanie Davies; Taudeusz Derezinski; Gabrielle Martinez Ravn; Per Clauson; Philip Home
Journal: Diabetes Care Date: 2006-06 Impact factor: 19.112

4. Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.

Authors: H Yki-Järvinen; R Kauppinen-Mäkelin; M Tiikkainen; M Vähätalo; H Virtamo; K Nikkilä; T Tulokas; S Hulme; K Hardy; S McNulty; J Hänninen; H Levänen; S Lahdenperä; R Lehtonen; L Ryysy
Journal: Diabetologia Date: 2006-02-03 Impact factor: 10.122

5. Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.

Authors: C Fajardo Montañana; C Hernández Herrero; M Rivas Fernández
Journal: Diabet Med Date: 2008-08 Impact factor: 4.359

6. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients.

Authors: Matthew C Riddle; Julio Rosenstock; John Gerich
Journal: Diabetes Care Date: 2003-11 Impact factor: 19.112

6 in total

3 in total

1. Differential effects of adiposity on pharmacodynamics of basal insulins NPH, glargine, and detemir in type 2 diabetes mellitus.

Authors: Francesca Porcellati; Paola Lucidi; Paolo Rossetti; Paola Candeloro; Anna Marinelli Andreoli; Stefania Marzotti; Patrizia Cioli; Geremia B Bolli; Carmine G Fanelli
Journal: Diabetes Care Date: 2011-10-04 Impact factor: 19.112

2. Impact of patient and treatment characteristics on glycemic control and hypoglycemia in patients with type 2 diabetes initiated to insulin glargine or NPH: A post hoc, pooled, patient-level analysis of 6 randomized controlled trials.

Authors: Francesca Porcellati; Jay Lin; Paola Lucidi; Geremia B Bolli; Carmine G Fanelli
Journal: Medicine (Baltimore) Date: 2017-02 Impact factor: 1.889

3. Prevention of tumour cell apoptosis associated with sustained protein kinase B phosphorylation is more sensitive to regulation by insulin signalling than stimulation of proliferation and extracellular signal-regulated kinase.

Authors: Christoph Schmid; Claudia Ghirlanda; Markus Niessen
Journal: Mol Cell Biochem Date: 2017-03-18 Impact factor: 3.396

3 in total